Julmentin 156.25mg/ 5mL Powder for Oral Suspension Филипини - Енглески - FDA (Food And Drug Administration)

julmentin 156.25mg/ 5ml powder for oral suspension

team excel distribution inc. - co-amoxiclav - powder for oral suspension - 156.25mg/ 5ml

Jusline N 100 Units/mL Sterile Suspension for Injection Филипини - Енглески - FDA (Food And Drug Administration)

jusline n 100 units/ml sterile suspension for injection

team excel distribution inc. - isophane insulin human (recombinant dna) - sterile suspension for injection - 100 units/ml

Jusline 30/70 100IU/mL(30%/70%) Suspension, for SC injection Филипини - Енглески - FDA (Food And Drug Administration)

jusline 30/70 100iu/ml(30%/70%) suspension, for sc injection

team excel distribution inc. - neutral insulin human , isophane human, recombinant dna - suspension, for sc injection - 100iu/ml(30%/70%)

Jusline R 100 Units/mL Sterile Solution for Injection SC Филипини - Енглески - FDA (Food And Drug Administration)

jusline r 100 units/ml sterile solution for injection sc

team excel distribution inc. - regular insulin human, recombinant dna - sterile solution for injection sc - 100 units/ml

CYSTEAMINE HYDROCHLORIDE powder Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

cysteamine hydrochloride powder

bluebay shandong co.,ltd - cysteamine hydrochloride (unii: if1b771svb) (cysteamine - unii:5ux2sd1ke2) -

CYSTAGON 150 MG Израел - Енглески - Ministry of Health

cystagon 150 mg

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

CYSTAGON 150 MG Израел - Енглески - Ministry of Health

cystagon 150 mg

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.